SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-007198
Filing Date
2022-03-24
Accepted
2022-03-24 17:23:01
Documents
15
Period of Report
2022-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blcm-20220324.htm   iXBRL 8-K 35097
2 EX-99.1 exh9912021q4earningsrelease.htm EX-99.1 107499
7 bellicumpressrel_image1a01a.gif GRAPHIC 21803
  Complete submission text file 0001628280-22-007198.txt   346276

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20220324.xsd EX-101.SCH 2156
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20220324_def.xml EX-101.DEF 14380
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20220324_lab.xml EX-101.LAB 27854
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20220324_pre.xml EX-101.PRE 14917
9 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20220324_htm.xml XML 10787
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 22767557
SIC: 2834 Pharmaceutical Preparations